Antioxidant Roles of SGLT2 Inhibitors in the Kidney
The reduction-oxidation (redox) system consists of the coupling and coordination of various electron gradients that are generated thanks to serial reduction-oxidation enzymatic reactions. These reactions happen in every cell and produce radical oxidants that can be mainly classified into reactive ox...
Main Authors: | Carmen Llorens-Cebrià, Mireia Molina-Van den Bosch, Ander Vergara, Conxita Jacobs-Cachá, Maria José Soler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/1/143 |
Similar Items
-
Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19
by: Beatriz Fernandez-Fernandez, et al.
Published: (2020-06-01) -
Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice
by: Ander Vergara, et al.
Published: (2022-10-01) -
Endothelin Receptor Antagonists in Kidney Disease
by: Irene Martínez-Díaz, et al.
Published: (2023-02-01) -
SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
by: Roko Skrabic, et al.
Published: (2022-10-01) -
The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status
by: Jennifer Matthews, et al.
Published: (2023-09-01)